Header Logo

Neilayan Sen

Concepts (71)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiation Oncology
3
2019
14
0.440
 Why?
Pancreatic Neoplasms
1
2014
88
0.400
 Why?
Employment
2
2018
40
0.270
 Why?
Chemoradiotherapy
2
2019
57
0.250
 Why?
Internship and Residency
2
2019
205
0.230
 Why?
Sarcoma
2
2019
141
0.230
 Why?
Carcinoma, Non-Small-Cell Lung
2
2017
236
0.210
 Why?
Lung Neoplasms
2
2017
542
0.180
 Why?
Human papillomavirus 16
1
2019
6
0.150
 Why?
Oropharyngeal Neoplasms
1
2019
19
0.150
 Why?
Biopsy, Fine-Needle
1
2019
63
0.150
 Why?
Career Choice
1
2018
24
0.150
 Why?
Tongue Neoplasms
1
2018
18
0.140
 Why?
Neoadjuvant Therapy
2
2019
62
0.140
 Why?
Carcinoma, Squamous Cell
1
2019
164
0.140
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2019
240
0.130
 Why?
Radiosurgery
1
2017
32
0.130
 Why?
Prognosis
2
2019
740
0.120
 Why?
Brachytherapy
1
2016
44
0.120
 Why?
Radiotherapy, Adjuvant
1
2014
50
0.110
 Why?
Humans
10
2019
23355
0.110
 Why?
United States
4
2019
1829
0.100
 Why?
Retrospective Studies
4
2019
3040
0.080
 Why?
Treatment Outcome
4
2019
2989
0.080
 Why?
Male
6
2019
12655
0.070
 Why?
Female
6
2019
13149
0.070
 Why?
Chi-Square Distribution
2
2018
129
0.070
 Why?
Disease-Free Survival
2
2018
171
0.060
 Why?
Adult
4
2019
7078
0.060
 Why?
Databases, Factual
2
2019
314
0.060
 Why?
Neoplasm Staging
2
2018
359
0.060
 Why?
Cohort Studies
2
2019
1429
0.050
 Why?
Aged
3
2019
7562
0.050
 Why?
Genetic Heterogeneity
1
2019
9
0.040
 Why?
Mesna
1
2019
3
0.040
 Why?
Population Density
1
2018
7
0.040
 Why?
Job Application
1
2018
6
0.040
 Why?
Cities
1
2018
13
0.040
 Why?
Clinical Decision-Making
1
2019
43
0.040
 Why?
Ifosfamide
1
2019
13
0.040
 Why?
Reference Values
1
2019
167
0.040
 Why?
Organ Sparing Treatments
1
2019
12
0.040
 Why?
Leg
1
2019
40
0.040
 Why?
Schools, Medical
1
2018
26
0.040
 Why?
Consumer Behavior
1
2018
23
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2018
28
0.040
 Why?
Doxorubicin
1
2019
57
0.040
 Why?
Arm
1
2019
68
0.040
 Why?
Neoplasm Invasiveness
1
2018
89
0.040
 Why?
Analysis of Variance
1
2018
236
0.040
 Why?
Combined Modality Therapy
1
2019
296
0.040
 Why?
Survival Rate
1
2018
323
0.030
 Why?
Professional Practice Location
1
2017
2
0.030
 Why?
Academies and Institutes
1
2017
11
0.030
 Why?
Censuses
1
2017
8
0.030
 Why?
Radiotherapy Dosage
1
2017
93
0.030
 Why?
Patient Safety
1
2017
35
0.030
 Why?
Kaplan-Meier Estimate
1
2017
169
0.030
 Why?
Risk Assessment
1
2019
565
0.030
 Why?
Middle Aged
2
2019
8072
0.030
 Why?
Age Factors
1
2018
641
0.030
 Why?
Societies, Medical
1
2017
122
0.030
 Why?
Registries
1
2017
176
0.030
 Why?
Chemoradiotherapy, Adjuvant
1
2015
15
0.030
 Why?
Survival Analysis
1
2015
245
0.030
 Why?
Surveys and Questionnaires
1
2018
1039
0.030
 Why?
Follow-Up Studies
1
2017
1441
0.030
 Why?
Young Adult
1
2018
1676
0.030
 Why?
Adolescent
1
2018
1917
0.030
 Why?
Prospective Studies
1
2017
1524
0.020
 Why?
Aged, 80 and over
1
2017
3785
0.020
 Why?
Sen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_